WEDNESDAY, Oct. 1, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, with or without astigmatism, and to slow the progression of the disease in children 6 to 12 years old.

The Essilor Stellest eyeglass lenses have a clear 9-mm diameter area in the center that is surrounded by peripheral lenslets (rings of tiny, raised dots), which provide peripheral light defocus that may help to slow the progression of myopia in children. Myopia typically progresses in school-aged children when their eyes are still growing. Prior to Essilor Stellest eyeglass lenses, the only approved device for slowing the progression of myopia was contact lenses for 8- to 12-year-olds. The Essilor Stellest eyeglass lenses pr

See Full Page